Evidence map›Paper›PMID 32162580›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2021

Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study.

Kelsi A Smith, Sarah Burkill, Ayako Hiyoshi, Tomas Olsson, Shahram Bahmanyar, David Wormser, Yvonne Geissbühler, Alan Moore, Vineetkumar Kharat, Scott Montgomery

Abstract read
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Excess costs of multiple sclerosis: a register-based study in Sweden.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Observational
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kelsi A SmithClinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden/Department of Translational Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9811-908X
Sarah BurkillClinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden/Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Ayako HiyoshiClinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden/Department of Public Health Sciences, Stockholm University, Stockholm, Sweden.
Tomas OlssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Shahram BahmanyarClinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden/Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden/Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
David WormserF. Hoffmann-La Roche Ltd., Basel, Switzerland.
Yvonne GeissbühlerNovartis Pharma AG, Basel, Switzerland.
Alan MooreNovartis Pharma AG, Basel, Switzerland.
Vineetkumar KharatNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Scott MontgomeryClinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden/Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden/Department of Epidemiology and Public Health, University College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople with multiple sclerosis (pwMS) have increased comorbid disease (CMD) risk. Most previous studies have not considered overall CMD burden.

objectiveTo describe lifetime CMD burden among pwMS.

methodsPwMS identified using Swedish registers between 1968 and 2012 (

resultsThe magnitude of the PRs for each CMD and age group decreased across time, with higher PRs in earlier time periods. Before 1990, younger age groups had higher PRs, and after 1990, older age groups had higher PRs. Male pwMS had higher burden compared with females. Overall, renal, respiratory, and seizures had the highest PRs. Before 2001, 50% of pwMS received a first/additional CMD diagnosis 20 years prior to people without MS, which reduced to 4 years after 2001. PwMS had four times higher rates of first/additional diagnoses in earlier time periods, which reduced to less than two times higher in recent time periods compared to people without MS.

conclusionSwedish pwMS have increased CMD burden compared with the general population, but this has reduced over time.

Indexed as

Cost of IllnessMultiple SclerosisAgedCohort StudiesFemaleHumansMaleRegistriesSwedenburdenchronic diseasecohortcomorbidityMultiple sclerosisprevalenceregistriesSweden

Identifiers

PMID32162580
PMCPMC7820574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.